I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
First-Line Pembrolizumab Monotherapy for Advanced NSCLC Wit..:
Yasushi Goto, MD, PhD
;
Atsuhisa Tamura, MD, PhD
;
Hirotaka Matsumoto, MD
...
http://www.sciencedirect.com/science/article/pii/S2666364322001217. , 2022
Link:
https://doi.org/10.1016/j.jtocrr.2022.100397
RT Journal T1
First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:6c1d51a111954179b8993ec6b3e61d62&Exemplar=1&LAN=DE A1 Yasushi Goto, MD, PhD A1 Atsuhisa Tamura, MD, PhD A1 Hirotaka Matsumoto, MD A1 Kazutoshi Isobe, MD, PhD A1 Tomohiro Ozaki, MD A1 Melissa L. Santorelli, PhD, MPH A1 Kazuko Taniguchi, MS A1 Tetsu Kamitani, MD, PhD A1 Masato Irisawa, PhD A1 Kingo Kanda, MPharm A1 Machiko Abe, MS A1 Thomas Burke, PharmD, PhD A1 Hiroshi Nokihara, MD, PhD PB Elsevier YR 2022 K1 Non–small cell lung cancer K1 Older adults K1 Pembrolizumab K1 Real-world progression-free survival K1 Survival K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S2666364322001217 LK http://dx.doi.org/https://doi.org/10.1016/j.jtocrr.2022.100397 DO https://doi.org/10.1016/j.jtocrr.2022.100397 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)